Clinical experience with synthetic serum substitute as a protein supplement in IVF culture media: A retrospective study
Objective: Our objective was to evaluate the efficacy of Synthetic Serum Substitute (Irvine Scientific—Materials Section, Santa Ana, CA), a globulin-enriched protein preparation containing human serum albumin for supplementation of IVF culture media.
Design: We retrospectively analyzed IVF cycles performed at MacDonald Womens Hospital between January 1992 and November 1994. IVF cycles were reviewed and classified according to the nature of protein supplementation used in the embryo culture medium. Three protein supplements utilized during this time period were compared: Synthetic Serum Substitute (SSS), Plasmanate (PL), and maternal serum (MS).
Results: Although clinical pregnancy rates among the three treatment groups were not statistically different, there was a definite trend toward a higher pregnancy rate with SSS supplementation (SSS, 38.2%; MS, 28.0%; and PL, 24.9%). Embryos grown in SSS-supplemented culture media had a significantly higher implantation rate (17.8 vs 10.4 and 10.3%, respectively, for MS and PL). Preliminary data also suggest that human embryo development and blastulation in vitro were enhanced by this protein supplement.
Conclusions: The higher implantation rate with SSS suggests that it may be superior to both maternal serum and Plasmanate in supporting human embryo development in vitro. Whether blastocysts derived from PL- and SSS-supplemented media are able to implant and give rise to clinical pregnancies remains to be seen.
Key wordsculture medium human embryo in vitro fertilization protein supplement synthetic serum
Unable to display preview. Download preview PDF.
- 4.Caro CM, Trounson A: The effect of protein on preimplantation mouse embryo development in vitro. J Vitro Fert Embryo Transfer 1984;1:183–187Google Scholar
- 5.Holst N, Bertheussen K, Forsdahl F, Hakonsen M, Hansen L, Nielsen H: Optimization and simplification of culture conditions in human in vitro fertilization (IVF) and preembryo replacement by serum-free media. J Vitro Fert Embryo Transfer 1990;7(1):47–53Google Scholar
- 12.Oskenberg JR, Brautar C: In vitro suppression of murine blastocyst growth by sera from women with reproductive disorders. Am J Reprod Immunol 1986;11:118–124Google Scholar
- 13.Caro CM, Trounson A: Successful fertilization, embryo development, and pregnancy in human in vitro fertilization (IVF) using a chemically defined culture medium containing no protein. J Vitro Fert Embryo Transfer 1986;3:215Google Scholar
- 14.Kruger TF, Stander FSH, Smith K, Van der Merwe JP, Lombard CJ: The effect of serum supplementation on the cleavage of human embryos. J Vitro Fert Embryo Transfer 1987;4:10Google Scholar
- 15.Pope AK, Harrison KL, Wilson LM, Breen TM, Cummins JM: UltroSerG as a serum substitute in embryo culture medium. J Vitro Fert Embryo Transfer 1987;4:286Google Scholar
- 17.Cummins JM, Breen TM, Harrison KL, Shaw JM, Wilson LM, Hennesey JF: A formula for scoring human embryo growth rates in in vitro fertilization: Its value in predicting pregnancy and in comparison with visual estimates of embryo quality. J Vitro Fertil Embryo Transfer 1986;3:284–295Google Scholar